IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Adicet BIO Inc (TORCEUR)

CUSIP: 007002108 | X1 | 259 institutional holders

Quarters

Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13D/AOrbimed Advisors LLC
with Orbimed Capital GP V LLC, Orbimed Capital GP VI LLC, Orbimed Advisors Israel II LTD, +4 more
844,7878.8%−13,927,811Apr 8, 2026190d ahead of 13F (11,447,140 sh) · −10,602,353
13D/AOrbimed Advisors LLC844,787
8.8% of class · Apr 8, 2026−13,927,811
with Orbimed Capital GP V LLC, Orbimed Capital GP VI LLC, Orbimed Advisors Israel II LTD, +4 more
190d ahead of 13F (11,447,140 sh) · −10,602,353

Institutional Holders — Q1 2026

Regeneron Pharmaceuticals, Inc.60,511
0.9% of portfolio›$412.1K
StyleTurnoverLocationFiled
Regeneron Pharmaceuticals, Inc.
60,511$412.1K0.9%Deep ValueVery LowTarrytown, NY2026-05-08